本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示 ● 上海岱美汽车内饰件股份有限公司（以下简称"公司"）实际控制人之一姜明先生目前直接持有公司股 份133,176,585股，占公司目前总股本的6.20%。本次股份解除质押后，姜明先生累计质押公司股份 38,000,000股，占其所持公司股份的28.53%，占公司目前总股本的1.77%。 ● 姜明先生、姜银台先生、叶春雷先生、鞠文静女士、建信信托有限责任公司－建信信托－私人银行家 族信托单一信托12898号及浙江舟山岱美投资有限公司互为一致行动人。截至本公告披露日，前述一致 行动人合计持有公司股份1,740,395,236股，占公司目前总股本的81.00%。本次股份解除质押后，前述一 致行动人累计质押公司股份38,000,000股，占其所持公司股份的2.18%，占公司目前总股本的1.77%。 证券代码：603730 证券简称：岱美股份 公告编号：2025-057 债券代码：113673 债券简称：岱美转债 上海岱美汽车内饰件股份有限公司 关于公司实际控制人部分股份解除 ...

Core Viewpoint - Shenzhen Kinwong Electronics Co., Ltd. has announced the early redemption and delisting of its convertible bond "Jing 23 Convertible Bond" due to the triggering of conditional redemption clauses based on stock price performance [1][2][3] Redemption Details - The last trading day for "Jing 23 Convertible Bond" is September 25, 2025, with only 6 trading days remaining as of September 17, 2025 [2][18] - The last conversion date is September 30, 2025, with 9 trading days remaining as of September 17, 2025 [3][18] - The redemption price is set at 100.515 CNY per bond, which includes accrued interest [10][12] - The redemption date is October 9, 2025, when the bonds will be delisted from the Shanghai Stock Exchange [19][16] Conditions for Redemption - The conditional redemption was triggered as the company's stock price was above 130% of the conversion price for 15 trading days within a 30-day period [5][8] - The company has decided to exercise its right to redeem the bonds early to reduce financial costs and optimize its capital structure [6][8] Investor Guidance - Investors are advised to convert or sell their bonds within the specified time frame to avoid forced redemption [4][21] - The accrued interest calculation for the bonds is based on a 1.0% annual interest rate over 188 days [10][11] Tax Implications - Individual investors are subject to a 20% tax on interest income from the bonds, resulting in a net redemption amount of 100.412 CNY per bond after tax [13][14]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600179 证券简称：安通控股 公告编号：2025-059 安通控股股份有限公司 关于持股5%以上股东及其一致行动人权益变动后 持股比例触及1%整数倍的提示性公告 持股5%以上的股东中外运集装箱运输有限公司及其一致行动人中国外运股份有限公司保证向本公司提 供的信息内容真实、准确、完整、没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 ■ 一、信息披露义务人及其一致行动人的基本信息 安通控股股份有限公司（以下简称"公司"或"安通控股"）近日收到公司股东中国外运股份有限公司（以 下简称"中国外运"）出具的《关于增持安通控股股份持股比例触及1%的整数倍的告知函》，中国外运 于2025年8月29日至2025年9月16日通过集中竞价方式累计增持45,938,129股，增持股份比例约占公司总 股本的1.09%，中国外运及其一致行动人持股比例从17.00%增加至18.09%，其权益触及1%整数倍，具 体情况如下： ■ 三、其他说明 重要内容提示： 3、本次权益变动不涉及信息披露义务人披露权益变动报告书。 四 ...

Group 1 - The first extraordinary general meeting of shareholders for Nanjing Qixia Construction Co., Ltd. was held on September 17, 2025, at Xingye Plaza, Nanjing [2] - The meeting was conducted in compliance with the Company Law and the company's articles of association, utilizing both on-site and online voting methods [2][3] - All current directors and supervisors attended the meeting, with a total of 7 directors and 3 supervisors present [3] Group 2 - A significant resolution was passed to cancel the supervisory board and amend the company's articles of association, which received over two-thirds of the voting rights from attending shareholders [4][5] - The legal proceedings of the meeting were verified by Jiangsu Century Tongren Law Firm, confirming that the meeting's procedures and voting results were lawful and valid [6] Group 3 - Nanjing Gaoke Co., Ltd. holds 92.59308 million shares of Nanjing Qixia Construction, representing 8.818% of the total share capital [9] - Nanjing Gaoke plans to reduce its holdings by up to 31.5 million shares (not exceeding 3% of the total share capital) within three months, starting 15 trading days after the announcement [9] - The reduction will occur through a combination of centralized bidding (up to 10.5 million shares) and block trading (up to 21 million shares) [9]

Core Viewpoint - The company, Haosen Intelligent Manufacturing Co., Ltd., is set to hold a half-year performance briefing on September 25, 2025, to discuss its operational results and financial indicators for the first half of 2025, allowing investors to engage in Q&A sessions [2][3][5]. Group 1: Event Details - The investor briefing will take place on September 25, 2025, from 9:00 to 10:00 AM [5][6]. - The event will be conducted in an online interactive format via the Shanghai Stock Exchange Roadshow Center [3][5]. - Investors can submit questions from September 18 to September 24, 2025, through the Roadshow Center or via the company's email [2][7]. Group 2: Participation Information - Participants can access the briefing by logging into the Shanghai Stock Exchange Roadshow Center website [4][5]. - The company will address commonly raised questions during the briefing [3][7]. - Key personnel attending include the Chairman and General Manager, Mr. Dong Dexi, and the Financial Officer, Mr. Zhao Fanghao [6].

Core Viewpoint - The announcement highlights that Guangxi Wuzhou Zhongheng Group Co., Ltd.'s subsidiary, Chongqing Laimei Pharmaceutical Co., Ltd., has received drug registration certificates for two medications, Nicorandil Tablets and Ketorolac Tromethamine Injection, which will enhance the company's product line and market presence [1][3]. Group 1: Drug Registration Details - Chongqing Laimei Pharmaceutical has obtained registration for Nicorandil Tablets (5mg) and Ketorolac Tromethamine Injection (1ml:30mg) from the National Medical Products Administration [1][5]. - Nicorandil Tablets are indicated for the treatment of angina pectoris, originally developed by Daiichi Sankyo Co., Ltd. and launched in Japan in 1983, with sales in China starting in 2006 [1][2]. - Sales projections for Nicorandil Tablets in Chinese hospitals from 2022 to 2024 are estimated at CNY 676 million, CNY 789 million, and CNY 873 million, respectively [1][2]. Group 2: Market and Financial Impact - Ketorolac Tromethamine Injection is used for the short-term treatment of moderate to severe postoperative pain, developed by Roche and approved in China in 2005 [2]. - Sales projections for Ketorolac Tromethamine Injection in Chinese hospitals from 2022 to 2024 are estimated at CNY 2.643 billion, CNY 1.892 billion, and CNY 898 million, respectively [2]. - The total R&D investment for Nicorandil Tablets and Ketorolac Tromethamine Injection by Laimei Pharmaceutical is CNY 5.3879 million and CNY 4.7431 million, respectively [2].

证券代码：603266 证券简称：天龙股份公告编号：2025-025 宁波天龙电子股份有限公司 董事、高管减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 董事、高管持股的基本情况 截至本公告披露日，宁波天龙电子股份有限公司（以下简称"公司"）董事、总经理沈朝晖先生持有公司 股份1,281,000股，占公司总股本的0.64%。股份来源为IPO前取得的股份、公司2019年限制性股票激励 计划授予取得的股份以及上市后以资本公积转增股本方式取得的股份。 ● 减持计划的主要内容 登录新浪财经APP 搜索【信披】查看更多考评等级 (一)相关股东是否有其他安排 □是 √否 (二)大股东及董事、高管此前对持股比例、持股数量、持股期限、减持方式、减持数量、减持价格等是 否作出承诺 √是 □否 沈朝晖承诺：在任职期间内每年转让的公司股份数量将不超过其所持有的公司股份总数的百分之二十 五。如其出于任何原因离职，则在离职后半年内，其亦不转让或者委托他人管理其持有的公司股份；在 其申报离任六个月后的十二个 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603601 证券简称：再升科技公告编号：临2025-079 债券代码：113657 债券简称：再22转债 重庆再升科技股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东会召开日期：2025年10月10日 ● 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 一、召开会议的基本情况 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025年10月10日 14点30分 召开地点：重庆市渝北区回兴街道婵衣路1号重庆再升科技股份有限公司五楼会议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025年10月10日 至2025年10月10日 采用上海证券交易所 ...

证券代码：603280证券简称：南方路机 公告编号：2025-055 福建南方路面机械股份有限公司 关于选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 根据《中华人民共和国公司法》（以下简称"《公司法》"）《福建南方路面机械股份有限公司章程》 （以下简称"《公司章程》"）等有关规定，福建南方路面机械股份有限公司（以下简称"公司"）于2025 年9月16日召开职工代表大会，选举黄文景先生（简历详见附件）为公司第二届董事会职工代表董事， 任期自公司2025年第一次临时股东会审议通过新修订的《公司章程》之日起至第二届董事会届满之日 止。 黄文景先生原为公司第二届董事会非职工代表董事、总工程师，本次选举完成后，其变更为公司第二届 董事会职工代表董事，总工程师职务不变。 上述职工代表董事符合《公司法》《公司章程》等相关法律法规和制度规定的关于职工董事任职的资格 和条件。本次选举完成后，公司第二届董事会人员及各专门委员会成员构成不变，董事会中兼任高级管 理人员职务的董事以及由职工代表担任的董事人数总计未超过公司董事 ...

Core Points - The company announced a cash dividend of RMB 0.26 per share (before tax) for A-share holders [2][4] - The total cash dividend distribution amounts to approximately RMB 1.52 billion (before tax), with RMB 1.44 billion allocated to A-share holders [4] - The dividend distribution plan was approved by the board on August 28, 2025, following the authorization from the annual general meeting held on May 9, 2025 [2][3] Distribution Plan - The dividend is applicable to all A-share holders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the record date [3] - The total share capital of the company is 5,851,824,944 shares, with 5,560,600,544 shares being A-shares and 291,224,400 shares being H-shares [4] - The cash dividend will not be distributed to shares held in the company's repurchase account [3] Taxation Details - For individual A-share holders, dividends are subject to different tax treatments based on the holding period, with a maximum tax rate of 20% for shares held for less than one month [8][9] - For shares held over one year, dividends are exempt from individual income tax [8] - The net cash dividend for limited A-share holders and QFII investors will be RMB 0.234 per share after a 10% withholding tax [9][10] Implementation Method - The cash dividends will be distributed through the China Securities Depository and Clearing Corporation's clearing system to registered shareholders [6] - Shareholders who have not completed designated trading will have their dividends held until the completion of the necessary procedures [6] - The company will handle the distribution of dividends for specific shareholders, including major stakeholders [7]